Detection Test By Immunoassay Technique For Hiv-1 Antigen And Hiv-1 And Hiv-2 Antibodies in Pennsylvania
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Pennsylvania
| Provider | Medicare | Services |
|---|---|---|
| Quest Diagnostics Of Pennsylvania,... | $23.60 | 930 |
| Quest Diagnostics Venture Llc | $23.60 | 475 |
| Health Network Laboratories, Llc | $23.60 | 368 |
| Sma Medical, Inc. | $23.60 | 146 |
| Atlantic Diagnostic Laboratories,... | $23.60 | 96 |
| University Of Penn-Medical Group | $23.60 | 93 |
| Associated Clinical Laboratories | $23.60 | 88 |
| Guthrie Medical Group Pc | $23.60 | 82 |
| Zheng, Tim MD | $23.25 | 67 |
Pennsylvania Pricing in Context
In Pennsylvania, CPT code 87389 (Detection Test By Immunoassay Technique For Hiv-1 Antigen And Hiv-1 And Hiv-2 Antibodies) carries an average Medicare payment of $23.58 — 0% above the national benchmark of $23.55. 24 providers across the state submitted claims for this procedure in 2023, performing 2.4K total services. Individual payments in PA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Pennsylvania is $101.16, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Pennsylvania sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in Pennsylvania lands near $51.88, with self-pay cash prices typically around $45.50. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Detection Test By Immunoassay Technique For Hiv-1 Antigen And Hiv-1 And Hiv-2 Antibodies cost in Pennsylvania?
The average Medicare payment for Detection Test By Immunoassay Technique For Hiv-1 Antigen And Hiv-1 And Hiv-2 Antibodies in Pennsylvania is $23.58, which is 0% above the national average of $23.55. Providers in PA typically bill $101.16 for this procedure.
What does Detection Test By Immunoassay Technique For Hiv-1 Antigen And Hiv-1 And Hiv-2 Antibodies cost with insurance in Pennsylvania?
With commercial insurance in Pennsylvania, Detection Test By Immunoassay Technique For Hiv-1 Antigen And Hiv-1 And Hiv-2 Antibodies costs an estimated $51.88. Without insurance, the estimated cash price is $45.50. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Detection Test By Immunoassay Technique For Hiv-1 Antigen And Hiv-1 And Hiv-2 Antibodies in Pennsylvania?
24 providers in Pennsylvania billed Medicare for Detection Test By Immunoassay Technique For Hiv-1 Antigen And Hiv-1 And Hiv-2 Antibodies in 2023, performing 2.4K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Detection Test By Immunoassay Technique For Hiv-1 Antigen And Hiv-1 And Hiv-2 Antibodies cheaper in Pennsylvania than the national average?
No — Detection Test By Immunoassay Technique For Hiv-1 Antigen And Hiv-1 And Hiv-2 Antibodies costs 0% above the national average in Pennsylvania. The state average Medicare payment is $23.58 compared to $23.55 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.